Profitability on the horizon...
==============
NEW YORK, Apr 30, 2002 (BUSINESS WIRE) -- The Wall Street Transcript has published an in-depth interview with Robert Chioini, Chairman and CEO of Rockwell Medical Technologies (Nasdaq:RMTI), in which he talks at length about the company's future.
Chioini gives an overview of the company. "Rockwell is an innovative, US-based manufacturer and global distributor of high-quality hemodialysis products to the healthcare industry. The company supplies dialysis solutions and powders, blood tubing sets, fistula needles and other ancillary items needed for the dialysis treatment to be performed. The company currently operates two manufacturing plants located in Wixom, Michigan, and Grapevine, Texas."
Chioini explains, "The hemodialysis market is a $1 billion market. With our current product line, we're addressing a market worth approximately $300 million annually. A new product, a proprietary product, that we've just recently licensed the worldwide rights to addresses a $350 million market in just the U.S., and is as high as $750 million globally."
Looking forward, Chioini states, "We hope to be running at a profitable rate by the fourth quarter of this year. It's going to come down to how quickly we can bring on the business that we are currently securing; how quickly we can ramp up and start servicing those customers. There is no question that we'll be profitable. It's just a matter of how fast we can get there based on our book of business. So we're targeting the fourth quarter of this year, but if we experience any delays then it could be the first quarter of 2003."
This interview is part of a 77-page Top-Performing Small Cap Stocks Issue available at twst.com or by calling 212/952-7433
The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations. For subscription information call 800/246-7673.
============== |
